Maximus Berger

The association of plasma inflammatory markers with omega-3 fatty acids and their mediating role in psychotic symptoms and functioning: An analysis of the NEURAPRO clinical trial.

Subash Raj Susai, David Mongan, Colm Healy, Mary Cannon, Barnaby Nelson, Connie Markulev, Miriam R Schäfer, Maximus Berger, Nilufar Mossaheb, Monika Schlögelhofer, Stefan Smesny, Ian B Hickie, Gregor E Berger, Eric YH Chen, Lieuwe de Haan, Dorien H Nieman, Merete Nordentoft, Anita Riecher-Rössler, Swapna Verma, Andrew Thompson, et al.

Journal article  |  2021  |  Brain Behav Immun

BACKGROUND: There is increasing evidence that dysregulation of polyunsaturated fatty acids (FAs) mediated membrane function plays ..

Toxoplasma gondii, Herpesviridae and long-term risk of transition to first-episode psychosis in an ultra high-risk sample.

E Burkhardt, M Berger, RH Yolken, A Lin, HP Yuen, SJ Wood, SM Francey, A Thompson, PD McGorry, B Nelson, AR Yung, GP Amminger

Journal article  |  2021  |  Schizophr Res

BACKGROUND: Ultra high-risk (UHR) criteria were introduced to identify people at imminent risk of developing psychosis. To improve..

Cannabidiol for at risk for psychosis youth: A randomized controlled trial

G Paul Amminger, Ashleigh Lin, Melissa Kerr, Amber Weller, Jessica Spark, Charlotte Pugh, Sally O'Callaghan, Maximus Berger, Scott R Clark, James G Scott, Andrea Baker, Iain McGregor, David Cotter, Zoltan Sarnyai, Andrew Thompson, Alison R Yung, Brian O'Donoghue, Eoin Killackey, Cathy Mihalopoulos, Hok Pan Yuen, et al.

Journal article  |  2021  |  EARLY INTERVENTION IN PSYCHIATRY

BACKGROUND: No biological treatment has been firmly established for the at-risk stage of psychotic disorder. In this study we aim ..

Preventive interventions for individuals at ultra high risk for psychosis: An updated and extended meta-analysis

Cristina Mei, Mark van der Gaag, Barnaby Nelson, Filip Smit, Hok Pan Yuen, Maximus Berger, Marija Krcmar, Paul French, G Paul Amminger, Andreas Bechdolf, Pim Cuijpers, Alison R Yung, Patrick D McGorry

Journal article  |  2021  |  CLINICAL PSYCHOLOGY REVIEW

Intervention at the earliest illness stage, in ultra or clinical high-risk individuals, or indicated prevention, currently represe..

A validated method for the simultaneous quantification of cannabidiol, Delta(9)-tetrahydrocannabinol, and their metabolites in human plasma and application to plasma samples from an oral cannabidiol open-label trial

Richard C Kevin, Rebecca Vogel, Peter Doohan, Maximus Berger, G Paul Amminger, Iain S McGregor

Journal article  |  2021  |  DRUG TESTING AND ANALYSIS

Cannabidiol (CBD) and Δ9 -tetrahydrocannabinol (THC) are the two best known and most extensively studied phytocannabinoids within ..

Comparison of erythrocyte omega-3 index, fatty acids and molecular phospholipid species in people at ultra-high risk of developing psychosis and healthy people

Ayedh Alqarni, Todd W Mitchell, Patrick D McGorry, Barnaby Nelson, Connie Markulev, Hok Pan Yuen, Miriam R Schafer, Maximus Berger, Nilufar Mossaheb, Monika Schlogelhofer, Stefan Smesny, Ian B Hickie, Gregor E Berger, Eric YH Chen, Lieuwe de Haan, Dorien H Nieman, Merete Nordentoft, Anita Riecher-Rossler, Swapna Verma, Andrew Thompson, et al.

Journal article  |  2020  |  SCHIZOPHRENIA RESEARCH

People classified as ultra-high risk (UHR) of developing psychosis have reduced cellular membrane omega-3 and omega-6 polyunsatura..

Relationship between allostatic load and clinical outcomes in youth at ultra-high risk for psychosis in the NEURAPRO study

Maximus Berger, Suzie Lavoie, Patrick D McGorry, Barnaby Nelson, Connie Markulev, Hok-Pan Yuen, Miriam Schaefer, Zoltan Sarnyai, G Paul Amminger

Journal article  |  2020  |  SCHIZOPHRENIA RESEARCH

Individuals at ultra-high risk (UHR) for psychosis have an elevated risk of developing psychosis and other psychiatric outcomes. R..

Supplementation with the omega-3 long chain polyunsaturated fatty acids: Changes in the concentrations of omega-3 index, fatty acids and molecular phospholipids of people at ultra high risk of developing psychosis

Ayedh Alqarni, Todd W Mitchell, Patrick D McGorry, Barnaby Nelson, Connie Markulev, Hok Pan Yuen, Miriam R Schafer, Maximus Berger, Nilufar Mossaheb, Monika Schlogelhofer, Stephan Smesny, Ian B Hickie, Gregor E Berger, Eric YH Chen, Lieuwe de Haan, Dorien H Nieman, Merete Nordentoft, Anita Riecher-Rossler, Swapna Verma, Andrew Thompson, et al.

Journal article  |  2020  |  SCHIZOPHRENIA RESEARCH

Omega-3 long chain polyunsaturated fatty acids (n-3 LCPUFA) are necessary for optimum mental health, with recent studies showing l..

Treatment of social anxiety disorder and attenuated psychotic symptoms with cannabidiol.

Maximus Berger, Emily Li, Günter Paul Amminger

Journal article  |  2020  |  BMJ Case Reports

Anxiety disorders in young people are frequently comorbid with other mental disorders and respond unsatisfactorily to first-line t..

Omega-3 fatty acids and neurocognitive ability in young people at ultra-high risk for psychosis

Alison McLaverty, Kelly A Allott, Maximus Berger, Rob Hester, Patrick D McGorry, Barnaby Nelson, Connie Markulev, Hok Pan Yuen, Miriam R Schaefer, Nilufar Mossaheb, Monika Schloegelhofer, Stefan Smesny, Ian B Hickie, Gregor Emanuel Berger, Eric YH Chen, Lieuwe de Haan, Dorien H Nieman, Merete Nordentoft, Anita Riecher-Roessler, Swapna Verma, et al.

Journal article  |  2020  |  EARLY INTERVENTION IN PSYCHIATRY

BACKGROUND: Neurocognitive impairments are core early features of psychosis and are observed in those at ultra-high risk (UHR) for..